METHOD FOR PRODUCING HEAVY CHAIN AMINOCARBOXYLIC ACID

Abstract

The present invention relates to a method for producing a medium chain aminocarboxylic acid and, more particularly, to a recombinant microorganism in which a fatty aldehyde dehydrogenase gene in -oxidative metabolic pathway and a -oxidative metabolic pathway-related gene are deleted and a -transaminase gene is introduced, and a method for producing a medium chain aminocarboxylic acid by culturing the recombinant microorganism. The recombinant microorganism of the present invention can prevent additional oxidation of fatty aldehyde and -oxidative metabolism and also produce a medium chain aminocarboxylic acid, such as 12-aminodecane, as a raw material of nylon 12 from a substrate such as fatty acid with a high yield by introducing an amine group into a terminal thereof.

Claims

1. A recombinant microorganism from which a fatty aldehyde dehydrogenase gene in an -oxidative metabolism pathway and -oxidative metabolism pathway-related genes are deleted and into which an -transaminase gene is also introduced.

2. The recombinant microorganism of claim 1, wherein the fatty aldehyde dehydrogenase gene and the -oxidative metabolism pathway-related genes are deleted from all homologous genes present in the microorganism.

3. The recombinant microorganism of claim 1, wherein the fatty aldehyde dehydrogenase gene and the -oxidative metabolism pathway-related genes are deleted from some of the homologous genes present in the corresponding microorganism.

4. The recombinant microorganism of claim 1, wherein the fatty aldehyde dehydrogenase gene is selected from the group consisting of FALDH1, FALDH2, FALDH3, and FALDH4 genes.

5. The recombinant microorganism of claim 4, wherein each of the FALDH1, FALDH2, FALDH3, and FALDH4 genes comprise base sequences set forth in SEQ ID NOs: 1 to 4.

6. The recombinant microorganism of claim 1, wherein the -oxidative metabolism pathway-related gene is an acyl-CoA oxidase gene.

7. The recombinant microorganism of claim 6, wherein the acyl-CoA oxidase gene is selected from the group consisting of ACO1, ACO2, ACO3, ACO4, ACO5, and ACO6 genes.

8. The recombinant microorganism of claim 7, wherein each of the ACO1, ACO2, ACO3, ACO4, ACO5, and ACO6 genes comprise base sequences set forth in SEQ ID NOs: 5 to 10, respectively.

9. The recombinant microorganism of claim 1, wherein the -transaminase gene comprises a base sequence set forth in SEQ ID NO: 11.

10. The recombinant microorganism of claim 1, wherein the microorganism is a yeast or Escherichia coli.

11. The recombinant microorganism of claim 10, wherein the yeast is selected from the group of the yeast consisting of Yarrowia sp., Saccharomyces sp., Pichia sp., and Candida sp.

12. The recombinant microorganism of claim 11 wherein the yeast of Yarrowia sp. is Yarrowia lipolytica.

13. A method for producing a medium chain aminocarboxylic acid, comprising: (1) preparing the recombinant microorganism according to claim 1; and (2) treating the recombinant microorganism with a substrate to culture the recombinant microorganism.

14. The method of claim 13, wherein the substrate is a fatty acid.

15. The method of claim 14, wherein the fatty acid is a fatty acid having 5 to 30 carbon atoms.

16. The method of claim 15, wherein the fatty acid is dodecanoic acid.

17. The method of claim 13, wherein the medium chain aminocarboxylic acid is a medium chain aminocarboxylic acid compound having 5 to 30 carbon atoms.

18. The method of claim 17, wherein the medium chain aminocarboxylic acid is 12-aminododecanoic acid.

Description

DESCRIPTION OF DRAWINGS

[0016] FIG. 1 is a diagram showing types of products and related enzymes associated with -oxidative and -oxidative metabolism reactions.

[0017] FIG. 2 is a diagram schematically showing a process of preparing a recombinant microorganism of the present invention from which a fatty aldehyde dehydrogenase gene associated with -oxidation and -oxidative metabolism pathway-related genes are deleted and into which an -transaminase gene is also introduced.

[0018] FIG. 3 is a diagram schematically showing a vector containing an ura3 gene to be used as a selective marker for gene knockout to modify a strain, and a pop-out region for deleting the ura3 gene after insertion of a knock-out cassette.

[0019] FIG. 4 is a schematic diagram showing a process of constructing a knock-out cassette used to prepare a transformant microorganism according to the present invention.

[0020] FIG. 5 is a diagram schematically showing a transformation vector containing an -transaminase gene for the purpose of modifying a strain.

[0021] FIG. 6 is a graph illustrating types of transduced knock-out genes in the transformant microorganism according to the present invention.

[0022] FIG. 7 is a graph illustrating an amount of a medium chain aminocarboxylic acid produced from the dodecanoic acid substrate, using the transformant microorganism according to the present invention.

[0023] FIG. 8 is a graph illustrating an amount of the medium chain aminocarboxylic acid produced from the dodecanoic acid substrate, when an Y2-36 strain of the present invention is cultured in a flask.

[0024] FIG. 9 shows the GC/MS data showing that the medium chain aminocarboxylic acid is produced from the dodecanoic acid substrate in the Y2-36 strain according to the present invention.

BEST MODE

[0025] To achieve the objectives of the present invention, the present invention provides a recombinant microorganism from which a fatty aldehyde dehydrogenase gene in an -oxidative metabolism pathway and -oxidative metabolism pathway-related genes are deleted and into which an -transaminase gene is also introduced.

[0026] In the present invention, the term -oxidation refers to a metabolic process in which the terminal methyl group of a fatty acid is oxidized to form dicarboxylic acid, and the term (3-oxidation refers to a metabolic process in which a carbon atom at the -position in a carboxyl group is oxidized to release acetyl-CoA, whereby fatty acids are gradually decomposed into fatty acids whose number of carbon atoms is reduced by two. The concept of the - and -oxidations and the enzymes involved in such metabolic processes are widely known to persons having ordinary skill in the field of biochemistry. For example, when a fatty acid is used as the substrate for -oxidation, an -hydroxy fatty acid is first produced by means of an action of cytochrome P450 and an NADPH-cytochrome P450 reductase. Then, the -hydroxy fatty acid is converted into -aldehyde fatty acid by an action of a fatty alcohol dehydrogenase and a fatty alcohol oxidase, and the -aldehyde fatty acid is converted into dicarboxylic acid by an action of a fatty aldehyde dehydrogenase. Also, for the -oxidation, a fatty acid whose number of carbon atoms is reduced by two is produced by an acyl-CoA oxidase (see FIG. 1).

[0027] Transaminase (TA, EC 2.6.1.X) is an enzyme which exists widely in nature and is involved in the transfer of an amine group in the nitrogen metabolism of an organism. Generally, transaminases serve to remove an amino group from one amino acid to transfer the amino group to another -keto acid. The transaminases are used to produce optically pure non-natural amino acids and amine compounds because the transaminases have various outstanding advantages in that they exhibit wide specificity to substrates, high optical selectivity, a rapid reaction rate, and superior stability, and have no need for reproduction of coenzymes, and the like. The transaminases may be classified into five groups depending on the structures and multisequence alignments of proteins found in the Pfam database. Among these, the transaminases belonging to Group III including an -amino acid:pyruvate transaminase, an ornithine transaminase, a 4-aminobutyrate transaminase, and the like are referred to as -transaminases. Unlike the typical transaminases, the -transaminases perform a reaction of transferring an amine group of an amino acid- or carboxyl group-free amine compound, which contains an amine group at a position other than the -position, to an amine receptor such as 2-ketoglutarate or pyruvate. Therefore, the -transaminases may be used as enzymes very useful for production of optically active amine compounds. For example, the -transaminases were first employed at 1990 by Celgene Co. (USA) to synthesize chiral amines. In recent years, the -transaminases have been importantly employed for studies on asymmetric synthesis of chiral amines and studies on improvement of kinetic resolution. In 2012, Evonik Industries AG (Germany) reported one case in which 12-oxolauric acid methyl ester is converted into 12-aminolauric acid methyl ester using an -transaminase of a Chromobacterium violaceum DSM30191 strain.

[0028] According to an embodiment of the present invention, the fatty aldehyde dehydrogenase gene is preferably deleted from all homologous genes present in the corresponding microorganism, but a recombinant microorganism from which some of these genes are deleted may also be applied to the present invention, when necessary.

[0029] According to an embodiment of the present invention, the fatty aldehyde dehydrogenase gene may be selected from the group consisting of FALDH1, FALDH2, FALDH3, and FALDH4 genes, but the present invention is not limited thereto. The FALDH1, FALDH2, FALDH3, and FALDH4 genes may comprise base sequences set forth in SEQ ID NOs: 1 to 4, respectively, but the present invention is not limited thereto.

[0030] According to another embodiment of the present invention, the -oxidative metabolism pathway-related genes are preferably deleted from all homologous genes present in the corresponding microorganism, but a recombinant microorganism from which some of these genes are deleted may also be applied to the present invention, when necessary. The -oxidative metabolism pathway-related genes preferably includes an acyl-CoA oxidase gene, and the acyl-CoA oxidase gene may be selected from the group consisting of ACO1, ACO2, ACO3, ACO4, ACO5, and ACO6 genes, but the present invention is not limited thereto (see FIG. 2). According to other preferred embodiments of the present invention, the ACO1, ACO2, ACO3, ACO4, ACO5, and ACO6 genes may comprise base sequences set forth in SEQ ID NOs: 5 to 10, respectively, but the present invention is not limited thereto.

[0031] According to another embodiment of the present invention, the -transaminase gene may comprise a base sequence set forth in SEQ ID NO: 11, but the present invention is not limited thereto.

[0032] In the present invention, the recombinant microorganism from which the fatty aldehyde dehydrogenase gene and the -oxidative metabolism pathway-related genes are deleted and into which the -transaminase gene is also introduced may be prepared using conventional genetic recombinant technology known in the related art. In the present invention, the term deletion is used as a meaning generally encompassing a physical deletion of part or all of the corresponding gene, and also encompassing a situation in which a protein is not expressed from mRNA transcribed from the corresponding gene and a situation in which a protein expressed from the corresponding gene does not function. Also, the term introduction is used as a meaning generally encompassing all situations in which a gene is inserted into the genome of a microorganism, or a gene is expressed without insertion of the corresponding gene into the genome of the microorganism. Examples of the genetic recombinant technology that may be used herein may include methods such as transformation, transduction, transfection, microinjection, electroporation, and the like, but the present invention is not limited thereto.

[0033] In the present invention, any microorganisms having both -oxidative and -oxidative metabolism processes may be used without limitation. For example, eukaryotes including a yeast and prokaryotes including Escherichia coli may be used. According to an embodiment of the present invention, the yeast is preferably used as the microorganism. In this case, yeasts such as Yarrowia sp., Saccharomyces sp., Pichia sp., Candida sp., and the like may be used as the yeast without limitation. Among theses, Yarrowia lipolytica, Candida tropicalis, Candida infanticola, Saccharomyces cerevisiae, Pichia alcoholophia, or Candida mycoderma is preferably used. Yarrowia lipolytica is more preferably used.

[0034] As described above, in the case of the microorganism from which the fatty aldehyde dehydrogenase gene and the -oxidative metabolism pathway-related gene are deleted and into which the -transaminase gene is also introduced, when a fatty acid is supplied as the substrate, an opposite terminal of a carboxyl group is oxidized by an action of cytochrome P450 and an NADPH-cytochrome P450 reductase to form an alcohol. Then, a hydroxyl group of the alcohol is oxidized by an action of a fatty alcohol dehydrogenase and a fatty alcohol oxidase to form an aldehyde. However, because the fatty aldehyde dehydrogenase is deletion, no further oxidation occurs anymore. Also, the fatty acid aldehyde thus formed is aminated by an action of an -transaminase to form an aminocarboxylic acid.

[0035] Also, the present invention provides a method for producing a medium chain aminocarboxylic acid, which comprises:

[0036] (1) preparing a recombinant microorganism from which a fatty aldehyde dehydrogenase gene in an -oxidative metabolism pathway and -oxidative metabolism pathway-related genes are deleted and into which an -transaminase gene is also introduced; and

[0037] (2) treating the recombinant microorganism with a substrate to culture the recombinant microorganism.

[0038] In the present invention, the recombinant microorganism, from which the fatty aldehyde dehydrogenase gene in the -oxidative metabolism pathway and the -oxidative metabolism pathway-related genes are deleted and into which the -transaminase gene is also introduced, may be used to produce a medium chain aminocarboxylic acid with high yield by preventing additional oxidation and -oxidative metabolism of fatty acid aldehydes and introducing an amine group to the medium chain aldehyde fatty acid as well. The fatty aldehyde dehydrogenase gene and the -oxidative metabolism pathway-related genes are preferably deleted from all homologous genes present in the corresponding microorganism, but a recombinant microorganism from which some of these genes are deleted may also be applied to the present invention, when necessary.

[0039] In the present invention, any microorganisms having both -oxidative and -oxidative metabolism processes may be used without limitation. For example, eukaryotes including a yeast and prokaryotes including Escherichia coli may be used. According to an embodiment of the present invention, the yeast is preferably used as the microorganism. In this case, yeasts such as Yarrowia sp., Saccharomyces sp., Pichia sp., Candida sp., and the like may be used as the yeast without limitation. Among theses, Yarrowia lipolytica, Candida tropicalis, Candida infanticola, Saccharomyces cerevisiae, Pichia alcoholophia, or Candida mycoderma is preferably used. Yarrowia lipolytica is more preferably used.

[0040] In the present invention, the recombinant microorganism from which the fatty aldehyde dehydrogenase gene and the -oxidative metabolism pathway-related genes are deleted and into which the -transaminase gene is also introduced may be prepared using conventional genetic recombinant technology known in the related art. In the present invention, the term deletion is used as a meaning generally encompassing a physical deletion of part or all of the corresponding gene, and also encompassing a situation in which a protein is not expressed from mRNA transcribed from the corresponding gene and a situation in which a protein expressed from the corresponding gene does not function. Also, the term introduction is used as a meaning generally encompassing all situations in which a gene is inserted into the genome of a microorganism, or a gene is expressed without insertion of the corresponding gene into the genome of the microorganism.

[0041] In the present invention, the medium chain aminocarboxylic acid is used as a meaning encompassing all medium chain aminocarboxylic acids having 5 to 30 carbon atoms, preferably 8 to 16 carbon atoms. According to preferred embodiments of the present invention, the medium chain aminocarboxylic acid is preferably 12-aminododecanoic acid having 12 carbon atoms, but the present invention is not limited thereto.

[0042] In the present invention, the substrate of step (2) may be a fatty acid, but the present invention is not limited thereto. According to an embodiment of the present invention, a fatty acid having 5 to 30 carbon atoms, preferably 8 to 16 carbon atoms, and more preferably dodecanoic acid having 12 carbon atoms may be used as the fatty acid, but the present invention is not limited thereto.

MODE FOR INVENTION

[0043] Hereinafter, the present invention will be described in further detail with reference to examples thereof.

[0044] However, it should be understood that the following examples are just preferred examples for the purpose of illustration only and is not intended to limit or define the scope of the invention.

Example 1: Construction of Knock-Out Cassette

[0045] A vector containing an ura3 gene to be used as a selective marker for gene knockout to modify a strain, and a pop-out region for deleting the ura3 gene after insertion of a knock-out cassette was constructed (FIG. 3). A Yarrowia-derived gene was used as the ura3 gene, and the pop-out region used to modify a strain had a total of four sequences, and was referenced from two genes. Here, a Bacillus-derived glutamate-producing gene was used as one of the genes, and a gene associated with a Salmonella- or cloning vector pHUKH-derived His operon was used as the other one. The primers and sequences thereof used to construct the pop-out vectors are listed in the following Table 1.

TABLE-US-00001 TABLE1 Pop-outVectors SEQID Names BaseSequences NOs HisG1 BglIIF aattgggcccagatctcagaccggttcagacaggat 13 EcoRIR tctctgggcggaattcggaggtgcggatatgaggta 14 NotIF tgTTTCTCGgcggccgccagaccggttcagacaggat 15 BamHIR TCCAACGCGTGGATCCggaggtgcggatatgaggta 16 HisG2 BglIIF aattgggcccagatctaacgctacctcgaccagaaa 17 EcoRIR tctctgggcggaattctcttctcgatcggcagtacc 18 NotIF tgTTTCTCGgcggccgcaacgctacctcgaccagaaa 19 BamHIR TCCAACGCGTGGATCCtatctcgatcggcagtacc 20 glt2 BglIIF aattgggcccagatctTCAGAACTTGCGCCGATAAA 21 EcoRIR tctctgggcggaattcCTTTGCCAGCTAGACCATAGAG 22 NotIF tgTTTCTCGgcggccgcTCAGAACTTGCGCCGATAAA 23 BamHIR TCCAACGCGTGGATCCCTTTGCCAGCTAGACCAT 24 AGAG glt3 BglIIF aattgggcccagatctATTGGCGGGTTCGTTACTT 25 EcoRIR tctctgggeggaattcCCTGGAAGAAGGCCGTATTATC 26 NotIF tgTTTCTCGgcggccgcATTGGCGGGTTCGTTACTT 27 BamHIR TCCAACGCGTGGATCCCCTGGAAGAAGGCCGTAT 28 TATC

[0046] A knock-out cassette was constructed as shown in FIG. 4. First, PCR of a homologous region (HR) to be knocked out from the genomic DNA of Yarrowia sp., and PCR of two 5- and 3-terminal fragments from a pop-out vector were carried out separately. Thereafter, each of the 5 HR and 3 HR was subjected to alignment PCR (2.sup.nd PCR) with a PO-ura3 region to construct a knock-out cassette. The primers and sequences thereof used to amplify the respective homologous regions are listed in Table 2.

TABLE-US-00002 TABLE2 GeneDeletions SEQ ID Names BaseSequences NOs ACO1 F1 TTCCTCAATGGTGGAGAAGA 29 R1 TCTTTATCCTGTCTGAACCGGTCTG 30 GTACCATAGTCCTTGCCATGC F2 ATCGCTACCTCATATCCGCACCTCC 31 CTTCTGTCCCCCGAGTTTCT R2 AAGAAGGGCTTGAGAGTCG 32 ACO2 F1 CCCAACAACACTGGCAC 33 R1 TCTTTATCCTGTCTGAACCGGTCTG 34 CTCCTCATCGTAGATGGC F2 ATCGCTACCTCATATCCGCACCTCC 35 gacaagacccgacaggc R2 AGACCAGAGTCCTCTTCG 36 ACO3 F1 Accttcacagagccaccca 37 R1 ATGGCTCTCTGGGCGgtgttgggggtgttgatgatg 38 F2 TTGTTGTGTTTCTCGcaaggttctcatcgaggcctg 39 R2 Aggaaaggtcgaagagtgctct 40 ACO4 F1 Actgcgagagcgatctg 41 R1 TCTTTATCCTGTCTGAACCGGTCTG 42 TTCATGAGCATGTAGTTTCG F2 ATCGCTACCTCATATCCGCACCTCC 43 gaggacgacaaagccggag R2 AGAGCAGAGTCCTCCTCAA 44 ACO5 F1 AACTTCCTCACAGGCAGCGAGC 45 R1 ATGGCTCTCTGGGCG 46 GAGTAGAGAGTGGGAGTTGAGGTC F2 ttgttgtgtttctcg 47 ccccgtcaaggacgctgag R2 ACAGTAAGGTGGGGCTTGACTC 48 ACO6 F1 AGTCCCTCAACACGTTTACCG 49 R1 TCTTTATCCTGTCTGAACCGGTCTG 50 CCATTTAGTGGCAGCAACGTT F2 ATCGCTACCTCATATCCGCACCTCC 51 GAGCTCTGATCAACCGAACC R2 AGGAAGGGTCTAATGACAGA 52 FALDH1 F1 AATCACTCCTCCTACGC 53 R1 TCTTTATCCTGTCTGAACCGGTCTG 54 TGGTCTCGGGGACACCTC F2 ATCGCTACCTCATATCCGCACCTCC 55 CCATCATCAAGCCCCGAA R2 ACCGACATAATCTGAGCAAT 56 FALDH2 F1 Accactaggtgagatcgag 57 R1 TCTTTATCCTGTCTGAACCGGTCTG 58 CTCCGACACTACCGGAACGC F2 ATCGCTACCTCATATCCGCACCTCC 59 CTTGCTCCCACAGTTGTT R2 GATCACCCAGAACCATAGC 60 FALDH3 F1 GTGACCCCCACCACGTCAC 61 R1 TCTTTATCCTGTCTGAACCGGTCTG 62 TTCTGACATTTTCAGCGCCAC F2 ATCGCTACCTCATATCCGCACCTCC 63 CCATTACGAGCGTTTGACGG R2 CAGGGCTGGGGACCACC 64 FALDH4 F1 TACCGACTGGACCAGATTC 65 R1 TCTTTATCCTGTCTGAACCGGTCTG 66 CGGCAGTGGCAATGATCTTAC F2 ATCGCTACCTCATATCCGCACCTCC 67 GACTCGATTCATCGCTCCTAC R2 CAAATCTTTCGGAAGATTCGG 68

[0047] The primers used to PCR-amplify the pop-out region and ura3 as two fragments are listed in Table 3.

TABLE-US-00003 TABLE3 Pop-outCassettes SEQ ID Names BaseSequences NOs HISG1 F cagaccggttcagacaggat 69 R ggaggtgcggatatgaggta 70 HISG2 F aacgctacctcgaccagaaa 71 R tcttctcgatcggcagtacc 72 glt2 F TCAGAACTTGCGCCGATAAA 73 R CTTTGCCAGCTAGACCATAGAG 74 glt3 F ATTGGCGGGTTCGTTACTT 75 R CCTGGAAGAAGGCCGTATTATC 76 Bipartite Ulura3cs2B Atgccctcctacgaagctcgagc 77 Ylura3F Ctcccaacgagaagctggcc 78

Example 2: Construction of Transduction Vector

[0048] To insert an -transaminase into a Yarrowia strain, a vector as shown in FIG. 5 was constructed. The primers used for this purpose are listed in Table 4.

TABLE-US-00004 TABLE4 TransaminaseVectors SEQID Names BaseSequences NOs EXP1-F ccaagcttggtaccgagctcaGagtttggcgcccgttttttc 79 EXP1-R CGTTGTTTTTGCATATGTGCTGTAGATATGTCTTGTGTG 80 TAA TEF-F ccaagcttggtaccgagctcaaactttggcaaagaggctgca 81 TEF-R CGTTGTTTTTGCATATGTTTGAATGATTCTTATACTCAG 82 AAG ALK1-F ccaagcttggtaccgagctcagatctgtgcgcctctacagaccc 83 ALK1-R CGTTGTTTTTGCATATGagtgcaggagtattctggggagga 84 XPR2t-F2 gtcgacgcaattaacagatagtttgccg 85 XPR2t-R3 ctcgagggatcccggaaaacaaaacacgacag 86 TA-F CATATGCAAAAACAACGTACTACCTCCC 87 TA-R gtcgacTTAGGCCAAACCACGGGCTTTC 88 ATATG2-ER-F actcctgcactCATatgtccaacgccctcaacctg 89 XTATG2-ER-F ccaatccaacacatatgtccaacgccctcaacctg 90 ER-R-1 CGTTGTTTTTGCATAGAACCGCCACCGCCGCTACCGC 91 CACCGCCCGAACCGCCACCGCCgaatcgtgaaatatccttgggct ER-R-2 CGTTGTTTTTGCATatgAGAACCGCCACCGCCGCTACC 92 GCCACCGCCCGAACCGCCACCGCCgaatcgtgaaatatccttgg gct ETATG2-ER-1 tgattacgccaagcttGagtttggcgcccgttttttc 93 ETATG2-ER-2 acaggttgagggcgttggacatATGTGCTGTAGATATGTCTTGTGT 94 GTAA TTATG2-ER-1 tgattacgccaagcttaaactttggcaaagaggctg 95 TTATG2-ER-2 acaggttgagggcgttggacatATGtttgaatgattcttatactcagaag 96 ER-F atgtccaacgccctcaacctg 97 ER-R-3 CGTTGTTTTTGCATAGAACCGCCACCGCCGCTAC 98

[0049] The transaminase cassettes were constructed in the same manner as in FIG. 4, except that, when two fragments of PCR products were obtained from the vector, the genes spanning from a promoter to ura3 were amplified to construct the cassettes. The primers used to construct the cassettes are listed in the following Table 5.

TABLE-US-00005 TABLE5 TransaminaseCassettes SEQ Names BaseSequences IDNOs TA-FALDH4-F1 TACCGACTGGACCAGATTC 99 TA-FALDH4-R1 CGGCAGTGGCAATGATCTTAC 100 TA-FALDH4-F2 ctcctctatggtctagctggcaaagACTCGATTCATCGCTCCTAC 101 TA-FALDH4-R2 CAAATCTTTCGGAAGATTCGG 102 ATATG2-F gtcggtaagatcattgccactgccgagatctgtgcgcctctacagac 103 ETATG2-F gtcggtaagatcattgccactgccgGagtttggcgcccgttttttc 104 TTATG2-F gtcggtaagatcattgccactgccgaaactttggcaaagaggctgc 105 XTATG2-F gtcggtaagatcattgccactgccgacgcgtggagagtttgggtt 106

[0050] The gene sequences used to modify the recombinant microorganism strain according to the present invention are listed in the sequence listing, and summarized in Table 6.

TABLE-US-00006 TABLE 6 Genes SEQ ID NOs Genes SEQ ID NOs FALDH1 1 ACO3 7 FALDH2 2 ACO4 8 FALDH3 3 ACO5 9 FALDH4 4 ACO6 10 ACO1 5 -transaminase 11 ACO2 6 Ura3 12

Example 3: Preparation of Recombinant Microorganism Strain

[0051] The knock-out cassette constructed in Example 1 and the transduction vector constructed in Example 2 were used to prepare a total of eight knock-out strains from which some of all of a fatty aldehyde dehydrogenase gene in an -oxidative metabolism pathway present in a wild-type Yarrowia strain and -oxidative metabolism pathway-related genes were deleted and into which an -transaminase gene was also introduced (FIG. 6). Specifically, a strain in which a gene was to be knocked out or be introduced was plated on an YPD plate, and cultured at 30 C. for 16 to 24 hours. The cultured cells were scraped with a loop, put into 100 L of a one-step buffer (45% PEG4000, 100 mM DTT, 0.1 L of LiAc, 25 g of single-strand carrier DNA), and vortexed. Thereafter, the knock-out cassette and the transduction vector (1 ng or more) were added thereto, and the resulting mixture was vortexed again, and then cultured at 39 C. for an hour. The cultured sample was loaded onto a selective medium (6.7 g/L of YNB without amino acids, and 20 g/L of glucose), and then cultured at 30 C. for 48 hours to screen the strains into which the constructed cassette was inserted. To check whether the cassettes were correctly inserted onto the genomes of the screened strains, PCR was then performed using the primers included in the gene deletions listed in Table 2.

[0052] To insert another cassette, a pop-out process was performed on the strain into which the cassette was inserted. The strain screened from the selective medium was inoculated in 2 mL of an YPD medium, and cultured at 30 C. for 16 hours, and 200 L of the culture broth was then spread on a 5 FOA medium (6.7 g/L of YNB without amino acids, 20 g/L of glucose, 0.8 g/L of 5 FOA, 0.1 g/L of uracil, and 0.1 g/L of uridine), and then cultured at 30 C. for 48 hours. The strains grown on the 5 FOA medium were picked, and spread on an YPD plate and a UD plate to screen the strains grown on the YPD plate. Also, a PCR process was again performed using the primers listed in Table 2 to check whether the ura3 gene was deleted from the strains. A knock-out process was performed on other genes of the Ura3-free strains.

Example 4: Culturing of Recombinant Microorganism Strain

[0053] A day earlier, the strain to be cultured and tested was inoculated in 2 mL of an YPD medium (Bacto Laboratories, 10 g/L of Yeast extract, 20 g/L of peptone, and 20 g/L of glucose), and grown at 30 C. and 200 rpm for a day. 2 mL of a growth medium (pH 6.0) having the compositions listed in Table 7 was put into a 24-well plate, and a pre-cultured culture broth was inoculated at 1%. Thereafter, the strains were cultured at 30 C. and 450 rpm for a day in a plate stirrer. The strains cultured for a day were inoculated at a volume of 900 L in a new plate containing 900 L of a conversion medium (pH 7.6) listed in Table 8, and 200 L of a substrate was added thereto at the same time. The resulting mixture was cultured at 30 C. and 450 rpm for a day. In this case, 10 g/L of dodecanoic acid dissolved in DMSO was used as the substrate.

TABLE-US-00007 TABLE 7 Growth Medium (pH 6.0) Components Concentration (g/L) Glucose 50 YNB w/o amino acid 6.7 Yeast extract 10 (NH.sub.4).sub.2SO4 5 Uracil 0.05 0.1M phosphate buffer Preparation of 0.1M potassium phosphate buffer at 25 C. Volume (mL) of Volume (mL) of pH 1M K.sub.2HPO.sub.4 1M KH.sub.2PO.sub.4 6.0 13.2 86.8

TABLE-US-00008 Conversion Medium (pH 7.6) Components Concentration (g/L) Glucose 30 YNB w/o amino acid 6.7 Yeast extract 3 (NH.sub.4).sub.2SO4 15 Uracil 0.05 L-alanine 10 0.1M phosphate buffer Preparation of 0.1M potassium phosphate buffer at 25 C. Volume (mL) of Volume (mL) of pH 1M K.sub.2HPO.sub.4 1M KH.sub.2PO.sub.4 7.6 86.6 13.4

[0054] As a result, it was revealed that the Y1-11 strain in which only the -oxidative metabolism pathway-related genes were knocked out did not produce 12-aminododecanoic acid from dodecanoic acid serving as the substrate, but all the Y2-20, Y-2-25, Y2-30, Y2-35, Y2-36 and Y3-1 strains in which the fatty aldehyde dehydrogenase gene were further knocked out and into which the -transaminase was introduced exhibited an excellent ability to synthesize 12-aminododecanoic acid (FIG. 7). Also, it was revealed that the Y2-36 strain exhibited an ability to synthesize approximately 8 mg/L of 12-aminododecanoic acid when cultured in the flask (FIG. 8). In the following experiment, a sample analysis test was performed using the Y2-36 strain.

Example 5: Sample Analysis

[0055] 100 L of 6 N sulfuric acid was added to 500 L of a culture broth of the Y2-36 strain, which had been proven to have the most excellent ability to synthesize 12-aminododecanoic acid in Example 4, and 500 L of methanol containing 10% toluene and 2.2% hydrochloric acid was added thereto to perform a methylation reaction. Thereafter, a methylation reaction was performed at 100 C. for an hour. 100 L of 10 N sodium hydroxide and 500 L of diethyl ether were added to the reaction solution, and the resulting mixture was thoroughly vortexed, and then centrifuged at 12,000 rpm for 2 minutes. Then, a GC/MS assay was performed under the following analytical conditions to separate only a solvent layer.

[0056] Analytical Conditions

[0057] {circle around (1)} Equipment: Agilent 5975 MSD

[0058] {circle around (2)} Column: HP-5MS

[0059] {circle around (3)} Temperature: Oven (150 C. to 230 C.)

[0060] {circle around (4)} Carrier Gas: He

[0061] {circle around (5)} Flow Rate: 1 mL/min.

[0062] As a result, it was confirmed that the recombinant Y2-36 strain of the present invention was able to synthesize 12-aminododecanoic acid from dodecanoic acid serving as the substrate (FIG. 9).